OpenOrbi

NatRural #coliving & #coworking

Una nueva forma de vivir y trabajar

[OpenOrbi @OpenOrbi]

Centro de coworking y coliving en El Burgo https://t.co/tphM7Dld78 vía @ElDiaDeSoria
.
#ruralshakers #coliving #coworking #emprendedores

[OpenOrbi @OpenOrbi]

$JILL is near $21.56, up roughly 9%.

Q2 EPS crushed estimates and management raised the full-year outlook.

Real earnings beat, real reaction.

Now I’m watching whether $21 holds

[OpenOrbi @OpenOrbi]

$SIG is around $98.79, up roughly 19.5%.

Q2 EPS beat estimates and full-year guidance was raised.

Volume is already well above normal.

Strong earnings, real participation — now I’m watching whether $100 becomes the next battle

[OpenOrbi @OpenOrbi]

$ODD is around $16.47, up roughly 26% premarket.

Q2 earnings are driving the move this morning.

Real catalyst, strong reaction.

After a gap this big, I’m watching the first pullback — not chasing it

[OpenOrbi @OpenOrbi]

$OKLO is around $43.16, up roughly 4.6% with 11M+ shares traded.

No fresh company headline today — this looks more like nuclear-sector strength.

That distinction matters.

I’m watching the move, but I’m not inventing a catalyst just to explain green

[OpenOrbi @OpenOrbi]

$BE is around $273.28, up roughly 8%.

The catalyst: Bloom Energy is heading into the S&P 500.

13M+ shares traded already.

Real event, real volume.

Now I want to see if the strength holds into the afternoon

[OpenOrbi @OpenOrbi]

$ISPC is around $1.88, up roughly 22%, with 7.5M+ shares traded premarket.

The catalyst: a $4.5M deal for Foldlab AI assets.

Huge volume for a tiny name.

Interesting momentum — but definitely not one I’d chase blindly

[OpenOrbi @OpenOrbi]

$VRXA is up roughly 16% near $1.77 with 3.4M shares traded.

Today’s catalyst is a new CFO appointment, and volume is running far above normal.

Not a huge headline — but the market reaction is hard to ignore

[OpenOrbi @OpenOrbi]

$WETO is still showing double-digit strength today.

Recent Physical AI and robotics updates keep traders interested.

But this one has been extremely volatile.

Momentum is real.

So is the risk.

I’m watching the pullbacks, not chasing the spike

[OpenOrbi @OpenOrbi]

$SMX is still showing momentum today, up roughly 14%.

Fresh product news brought attention, and price keeps pressing higher.

Small-cap momentum is real here.

I’m watching volume and pullbacks — not chasing the spike

[OpenOrbi @OpenOrbi]

$BBCP quietly looks strong this morning.

Around $10.52, up roughly 16%.

Revenue +13%, net income +33%, guidance raised — plus a new quarterly dividend.

Not flashy.

Just better numbers and a real catalyst

[OpenOrbi @OpenOrbi]

$AGX is one of the quieter earnings names I liked today.

Q2 EPS: $3.76 vs. $2.66 expected.
Revenue: record $384M, +62%.
Backlog: $2.8B.
Strong numbers without the usual social-media hype.
That’s my kind of setup

[OpenOrbi @OpenOrbi]

$SMMT is still holding roughly a 15% gain near $16.73.

The catalyst is meaningful: HARMONi-2 showed a survival advantage versus pembrolizumab.

Strong data got attention.

Now I want to see if the afternoon price action confirms it

[OpenOrbi @OpenOrbi]

$WOOF quietly has my attention today.

Better Q2 profitability, $75M more debt paid down, and full-year guidance held.

Not the flashiest mover — but I like seeing operational improvement behind the green.

Now I’m watching whether buyers can hold the earnings gap

[OpenOrbi @OpenOrbi]

$NYXH quietly caught my eye this morning.

Around $1.69, up roughly 12%, with 1.7M shares traded.

Its U.S. pivotal study hit both primary safety and efficacy endpoints.

Real clinical catalyst + unusual volume.

Now I want to see if buyers defend the move after the bell

[OpenOrbi @OpenOrbi]

$FCUV quietly turned into a +28% day near $14.50.

No fresh headline I’d confidently call the reason — and that matters.

Sometimes volume and price move before the story becomes obvious.

I’d rather admit I don’t know the catalyst than invent one.

[OpenOrbi @OpenOrbi]

Took a break, came back to the screen, and $PPBT is still hanging around the top of my small-cap list.

Around $2.20.
Up about 32%.
64M+ shares traded.
The cancer pipeline is giving traders something real to talk about, but this is exactly where I separate a good

[OpenOrbi @OpenOrbi]

Was checking a few charts before breakfast and one tiny gold name completely stole the screen.

$SGLD.

Roughly +260% premarket near $18, with millions of shares already traded.

The company just dropped new Goldwedge drilling results

[OpenOrbi @OpenOrbi]

Closing the laptop soon, but one small name is staying on tomorrow’s watchlist:

$BIAF.

Around $6.53, up roughly 43%, with volume exploding past 41M shares.

Not exactly the stock everyone was talking about over breakfast

[OpenOrbi @OpenOrbi]

Afternoon coffee and one chart keeps ending up back on my screen: $GPRO.

Still up around 44% near $1.26.

There’s plenty of excitement around the Starman deal and Markiplier’s stake, but this is where I stop caring about the headline and start watching price behavior.

[OpenOrbi @OpenOrbi]

One thing I’ve learned over the years:

The best morning movers don’t disappear by lunch.

$FRVO was trading around $19.14, up roughly 24%, with about 16.1M shares already changing hands.

The Google deal is the catalyst.
The volume is the confirmation.